Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7657)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2016 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peng R, Zhao GX, Li J, Zhang Y, Shen XZ, Wang JY, Sun JY. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo. World J Gastroenterol 2016; 22(12): 3341-3354 [PMID: 27022216 DOI: 10.3748/wjg.v22.i12.3341] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i12/3341.htm |
| Number | Citing Articles |
| 1 |
Pak Hin Chow, Joanne Bowen, Andrea J Yool. Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers. Cancers 2020; 12(7): 1911 doi: 10.3390/cancers12071911
|
| 2 |
Chatchaphan Udompatanakorn, Naomi Yada, Kou Matsuo. Assessing the Expression of Aquaporin 3 Antigen-Recognition Sites in Oral Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2020; 28(8): 611 doi: 10.1097/PAI.0000000000000802
|
| 3 |
Catarina Pimpão, Darren Wragg, Inês V. da Silva, Angela Casini, Graça Soveral. Aquaglyceroporin Modulators as Emergent Pharmacological Molecules for Human Diseases. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.845237
|
| 4 |
Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Dariusz Pawlak. Important players in carcinogenesis as potential targets in cancer therapy: an update. Oncotarget 2020; 11(32): 3078 doi: 10.18632/oncotarget.27689
|
| 5 |
Verodia Charlestin, Daniel Fulkerson, Carlos E. Arias Matus, Zachary T. Walker, Kevin Carthy, Laurie E. Littlepage. Aquaporins: New players in breast cancer progression and treatment response. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.988119
|
| 6 |
Lisha Chang, Zhe Bian, Xin Xiong, Jian Liu, Dali Wang, Fuling Zhou, Jiang Zhang, Yunhe Zhang. RETRACTED: Long Non-coding RNA LINC00320 Inhibits Tumorigenicity of Glioma Cells and Angiogenesis Through Downregulation of NFKB1-Mediated AQP9. Frontiers in Cellular Neuroscience 2020; 14 doi: 10.3389/fncel.2020.542552
|
| 7 |
Julian Reiß, Sebastian Kälble, Johannes Bründl, Bernd Rosenhammer, Michael Gierth, Florian Weber, Markus Eckstein, Ralph Markus Wirtz, Stefan Denzinger, Maximilian Burger, Wolfgang Otto, Johannes Breyer. Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer. Bladder Cancer 2021; 7(1): 71 doi: 10.3233/BLC-200400
|
| 8 |
Rui Wang, Xuejian Wang, Jun Zhao, Jiacheng Jin, Weiwei Fan, Xinqing Zhu, Qiwei Chen, Baochang Zhang, Lan Lan, Kexin Qu, Liang Zhu, Jianbo Wang. Clinical value and molecular mechanism of AQGPs in different tumors. Medical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01766-0
|
| 9 |
Verodia Charlestin, Elijah Tan, Carlos Eduardo Arias-Matus, Junmin Wu, Maria Cristina Miranda-Vergara, Mijoon Lee, Man Wang, Dharma T. Nannapaneni, Parinda Tennakoon, Brian S. J. Blagg, Brandon L. Ashfeld, William Kaliney, Jun Li, Laurie E. Littlepage. Evaluation of the Mammalian Aquaporin Inhibitors Auphen and Z433927330 in Treating Breast Cancer. Cancers 2024; 16(15): 2714 doi: 10.3390/cancers16152714
|